848
Participants
Start Date
July 27, 2024
Primary Completion Date
August 31, 2025
Study Completion Date
January 31, 2026
Diabetic Retinopathy screening Point of Care Artificial Intelligence
Random assignment of participants to intervention and control groups minimizes confounding variables. This ensures that any observed differences in outcomes are likely due to the intervention itself and not pre-existing differences between the groups. Participants of the DRES-POCAI study will be randomized into two groups: usual care (receive a retinal screening by an optometrist) or intervention group (receive a retinal screening using a special camera and EyeArt® system, an autonomous AI-based DR screening). The randomization will occur after consenting and completing the surveys, prior to conducting the DR screening process (for those randomized to the intervention group).
San Ysidro Health Chula Vista, Chula Vista
San Ysidro Health King-Chavez Health Center, San Diego
Eyenuk, Inc.
INDUSTRY
University of California, San Diego
OTHER
Centro De Salud La Comunidad De San Ysidro Inc DBA: San Ysidro Health
OTHER